Ketorolac Eg

Ketorolac, the active ingredient in Ketorolac Eg, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral dosage form for oral use. It provides short‑term relief of moderate to severe acute pain, including post‑operative and musculoskeletal pain, in adult patients.

GNH USA supplies Ketorolac Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketorolac is an NSAID that reduces pain and inflammation through cyclooxygenase inhibition.

Acute postoperative pain: provides rapid analgesia after surgical procedures. Musculoskeletal pain: alleviates pain associated with injuries or inflammatory conditions of muscles and joints. Severe acute pain: offers short‑term relief for conditions such as renal colic or trauma where prompt pain control is required.

Ketorolac may cause a range of adverse reactions.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia - Nausea or vomiting - Headache - Dizziness or vertigo - Constipation - Mild, reversible increase in serum creatinine

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Severe renal impairment or failure - Cardiovascular events such as myocardial infarction or stroke - Anaphylactic or severe allergic reactions - Hepatic dysfunction or jaundice - Thrombocytopenia or other hematologic abnormalities

Ketorolac should be used with caution and under medical supervision.

Renal function: assess baseline renal status and avoid use in severe renal impairment. Bleeding risk: use cautiously in patients receiving anticoagulants or with a history of ulcers. Cardiovascular: avoid in patients with uncontrolled hypertension or recent myocardial infarction. Pregnancy and lactation: prescribe only if benefits outweigh potential risks; safety not established. Drug interactions: review concomitant NSAIDs, anticoagulants, and ACE inhibitors before initiating therapy. Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original packaging.

Ketorolac can interact with several drug classes, requiring careful assessment.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal clearance and exacerbate renal effects. - Methotrexate: decreased excretion can lead to toxicity.